RxDoctor Payments Data

Zachary Rohr, DPM

Podiatrist · Baton Rouge, LANPI 1801352190

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (44.9%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Alpha Orthopedic Systems at 25.8% of the total. Reporting peaked in 2023 at $1,803 and has fallen 95.2% since, to $86 in 2025.

$3,709in general payments, 2019–2025

Across 48 payments — averaging $77.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alpha Orthopedic Systems$958
  • Treace Medical Concepts, Inc.$931
  • ALON Medical Technology$758
  • Arthrex$206
  • Integra Lifesciences Corporation$159
  • Organogenesis Inc.$158
  • plus $538 from 13 others

What the payments were for

  • Travel & lodging$1,66645%
  • Food & beverage$1,22533%
  • Education$81722%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,709 in reported general payments places this provider in the 60th percentile of 68 podiatrist providers in Louisiana.

See all podiatrist providers in Louisiana

Medicare billing

Part B allowed, 2024
$70,973
Medicare patients
184
Services billed
1,092

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox30$845
Mupirocin88$614
Ketoconazole17$261
Methylprednisolone27$171
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$166
Meloxicam48$120
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen18$111
Ibuprofen18$50

Paid to pharmacies, not to this prescriber.

Other podiatrist in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →